Clinical Research Blog Archives

Webinar: Transforming Study Start Up to Reduce Clinical Trial Site Burden

Clinical trials are more complex than ever. And 85% of them are delayed. More screening criteria, more procedures, new vendor systems and tools, and more data. So who bears the burden of all this progress? Sites. Increased site burden means degraded performance, more delays, and more problems for you. But it doesn't have

Posted on 15 Sep 2021
By Molly Bryant
In Clinical Research Blog, News

12 Clinical Trial Software Tools You Need to Run a Virtual Trial

It’s impossible to read an industry publication without hearing about virtual clinical trials, decentralized clinical trials, or hybrid trials. Industry leaders and technology companies are touting the advantages and the opportunities to anyone who will listen. You may understand the model, and you may recognize the effort to shift. But

Posted on 27 Aug 2021
By Molly Bryant
In Clinical Research Blog

Clinical Operations Conferences Roundup: 37 Events that Are Happening in 2021 [UPDATED]

Updated 22 July 2021. 2020 completely rocked the schedule of clinical operations conferences by the efforts to stave off the spread of COVID-19. Nearly every conference went virtual. Now with a vaccine on the horizon, we are all hoping to have at least some face to face clinical trial conferences in

Posted on 22 Jul 2021
By Molly Bryant
In Clinical Research Blog

Increasing Access to People of African Descent in Pharma: Interview with Peju Oshisanya

Peju Oshisanya joins Kelly Ritch, EVP of Product and Clinical Research Solutions at ArcheMedX, to discuss diversity and inclusion in clinical trials. An experienced clinical operations specialist and a strong advocate for data diversity, Peju shares her insight into the health sciences industry, evaluates opportunities for improvement, and illuminates the

Posted on 21 Jul 2021
By Molly Bryant
In Clinical Research Blog, Interviews

managing clinical trials despite complexity

Successful Clinical Trial Management Now Means Accepting Complexity. Here’s How to Deal with It.

If it shocks you to hear that clinical trials are getting more complex, you haven’t been paying attention. Specifically, we’re collecting more endpoints. We’re performing more procedures. We’re increasing nearly every executional variable, like the number of countries, the number of sites, the number of visits per patient, and the

Posted on 30 Jun 2021
By Molly Bryant
In Clinical Research Blog

As the Cost of Clinical Trials Climbs, Here Are 3 Ways to Save

By all accounts, the cost of clinical trials continues to rise. We hear reasons that include increasing protocol complexity, patient recruitment struggles, or regulatory challenges. And we shrug our shoulders. Most of us accept these rising costs and obstacles as a given. But - why? If you could predict the future problems

Posted on 29 Jun 2021
By Molly Bryant
In Clinical Research Blog

decentralized clinical trials mean training at scale

A Decentralized Clinical Trial Requires Training at Scale. Here’s What That Means.

The decentralized clinical trial is one of the most talked-about emerging trends in the life sciences industry. These sorts of clinical trials present immense benefits, as we wrote about in a recent blog. If executed well, the decentralized clinical trial design could both reduce resource consumption and accelerate treatments arrival to

Posted on 24 May 2021
By Molly Bryant
In Clinical Research Blog

5 Challenges in Working with CROs – and How to Overcome Them

You have a clinical trial starting soon. Are you working with a contract research organization, or at least planning to do so? Probably. In 2020, the ACRP estimated that 70% of clinical trials would involve sponsors working with CROs. And, as a result, 100% of those sponsors will encounter some

Posted on 21 May 2021
By Molly Bryant
In Clinical Research Blog

Ken Getz, Kelly Ritch on complexity in clinical trial protocols

How Can We Manage the Increasing Complexity of Clinical Trial Protocols?: Interview with Ken Getz of Tufts Center for the Study of Drug Development

Ken Getz joins Kelly Ritch, EVP of Product and Clinical Research Solutions at ArcheMedX, to discuss the growing complexity in clinical trial protocols. The Director of the Tufts Center for the Study of Drug Development and a Research Professor at the Tufts University School of Medicine, Ken shares his insights

Posted on 21 May 2021
By Molly Bryant
In Clinical Research Blog, Interviews

An Honest Look at How Demanding Oncology Trials Have Become: Interview with Rebecca Setta of Oncosec

Rebecca Setta joins Kelly Ritch, EVP of Product and Clinical Research Solutions at ArcheMedX, to discuss effective management of sites and teams through arduous clinical trials. Rebecca shares how she’s kept her team motivated and productive in spite of the added burdens imposed by the pandemic, and why she’s excited

Posted on 20 Apr 2021
By Molly Bryant
In Clinical Research Blog, Interviews

Category : Clinical Research Blog

Webinar: Transforming Study Start Up to Reduce Clinical Trial Site Burden

12 Clinical Trial Software Tools You Need to Run a Virtual Trial

Clinical Operations Conferences Roundup: 37 Events that Are Happening in 2021 [UPDATED]

Increasing Access to People of African Descent in Pharma: Interview with Peju Oshisanya

Successful Clinical Trial Management Now Means Accepting Complexity. Here’s How to Deal with It.

As the Cost of Clinical Trials Climbs, Here Are 3 Ways to Save

A Decentralized Clinical Trial Requires Training at Scale. Here’s What That Means.

5 Challenges in Working with CROs – and How to Overcome Them

How Can We Manage the Increasing Complexity of Clinical Trial Protocols?: Interview with Ken Getz of Tufts Center for the Study of Drug Development

An Honest Look at How Demanding Oncology Trials Have Become: Interview with Rebecca Setta of Oncosec

Subscribe

Request a Demo